US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

BCDA

BioCardia (BCDA)

BioCardia Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BCDA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/15	05 : 02	GlobeNewswire Inc.	BioCardia Reports First Quarter 2024 Business Highlights and Financial Results	NASDAQ:BCDA	BioCardia Inc
2024/05/01	20 : 00	GlobeNewswire Inc.	BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes	NASDAQ:BCDA	BioCardia Inc
2024/04/25	22 : 00	GlobeNewswire Inc.	BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort	NASDAQ:BCDA	BioCardia Inc
2024/03/28	05 : 00	GlobeNewswire Inc.	BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results	NASDAQ:BCDA	BioCardia Inc
2024/03/20	20 : 00	GlobeNewswire Inc.	BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024	NASDAQ:BCDA	BioCardia Inc
2024/03/13	20 : 00	GlobeNewswire Inc.	BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership	NASDAQ:BCDA	BioCardia Inc
2024/03/12	20 : 00	GlobeNewswire Inc.	BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study	NASDAQ:BCDA	BioCardia Inc
2024/03/04	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2024/03/04	22 : 00	GlobeNewswire Inc.	BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure	NASDAQ:BCDA	BioCardia Inc
2024/02/28	06 : 53	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:BCDA	BioCardia Inc
2024/02/15	21 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCDA	BioCardia Inc
2024/02/15	07 : 06	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BCDA	BioCardia Inc
2024/02/15	06 : 17	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:BCDA	BioCardia Inc
2024/02/09	23 : 58	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2024/02/08	21 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2024/02/08	21 : 00	GlobeNewswire Inc.	BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA	NASDAQ:BCDA	BioCardia Inc
2024/02/07	06 : 28	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:BCDA	BioCardia Inc
2024/02/03	04 : 06	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BCDA	BioCardia Inc
2024/01/31	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2024/01/31	21 : 00	GlobeNewswire Inc.	BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference	NASDAQ:BCDA	BioCardia Inc
2024/01/03	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2024/01/03	21 : 00	GlobeNewswire Inc.	BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholders	NASDAQ:BCDA	BioCardia Inc
2023/12/19	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2023/12/19	21 : 00	GlobeNewswire Inc.	BioCardia Doses First Patient in CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells for the Treatment of Ischemic Heart Failure of Reduced Ejection Fraction	NASDAQ:BCDA	BioCardia Inc
2023/12/18	21 : 16	GlobeNewswire Inc.	BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes	NASDAQ:BCDA	BioCardia Inc
2023/12/18	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2023/12/06	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2023/12/06	20 : 03	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:BCDA	BioCardia Inc
2023/12/06	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BCDA	BioCardia Inc
2023/12/06	06 : 11	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:BCDA	BioCardia Inc

Showing the most relevant articles for your search:NASDAQ:BCDA

1 2 3 4 5 6 7 8 9 10 次へ >>

Invesco QQQ Trust Series 1

Gold vs US Dollar

American Express

Bank of America

Verizon Communications

US Dollar vs Euro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約